Skip to main content

Table 1 Inclusion and exclusion criteria

From: The omega-3 and Nano-curcumin effects on vascular cell adhesion molecule (VCAM) in episodic migraine patients: a randomized clinical trial

People were considered as eligible if they meet all of the following criteria

People did not enter the trial if they meet one or more of the following criteria

Participants were excluded during the trial if they meet one or more of the following criteria

BMI greater than or equal to 18.5 kg/m2

A history or current diagnosis of kidney, liver or thyroid disorders, heart diseases, diabetes, different malignancies and other inflammatory comorbidities

Allergic reaction to W-3 or nanocurcumin supplements

Males and females 20–50 years of age

Low BMI (less than 18.5 kg/m2)

Lack of patient's cooperation

Episodic migraine

Dietary supplementation during the preceding three months

Pregnancy during the study period

Stable diet, physical activity or supplements during the trial

Pregnancy, lactation

Self-reported changes in diet and lifestyle

willingness to participate

Menopause

Changes in dosage or type of routine medications

 

Alcohol or drug abuse and cigarette smoking during

the preceding six months

Over 2 weeks anti-inflammatory drugs consumption

  

Compliance rate less than 90%